Medical and surgical evaluation and treatment of adrenal incidentalomas

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 7, 2011, Pages 2004-2015

  Zeiger, Martha A ^a   Siegelman, Stanley S ^a   Hamrahian, Amir H ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ATENOLOL; CALCIUM CHANNEL BLOCKING AGENT; DEXAMETHASONE; DOXAZOSIN; HYDROCORTISONE; METIROSINE; METOPROLOL; NORMETADRENALIN; PHENOXYBENZAMINE; RENIN;

ADRENAL CANCER; ADRENAL INCIDENTALOMA; ADRENALECTOMY; ASPIRATION BIOPSY; BEDTIME DOSAGE; BIOCHEMISTRY; CANCER RISK; CATECHOLAMINE BLOOD LEVEL; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CUSHINGOID SYNDROME; DIFFERENTIAL DIAGNOSIS; DROWSINESS; DRUG DOSE INCREASE; EJACULATION DISORDER; FOLLOW UP; HEART ARRHYTHMIA; HORMONE DETERMINATION; HUMAN; HYPERTENSION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MINIMALLY INVASIVE SURGERY; MORNING DOSAGE; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIOPERATIVE PERIOD; PHEOCHROMOCYTOMA; PLASMA RENIN ACTIVITY; POSTOPERATIVE CARE; PREOPERATIVE CARE; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; RADIATION ATTENUATION; REFERENCE VALUE; REVIEW; SENSITIVITY AND SPECIFICITY; STOMACH DISEASE; TACHYCARDIA; TREATMENT INDICATION; TUMOR GROWTH; TUMOR VOLUME; WEAKNESS;

ADRENAL GLAND NEOPLASMS; CUSHING SYNDROME; HUMANS; INCIDENTAL FINDINGS;

EID: 79960089147     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-0085     Document Type: Review

References (124)

1. Young Jr WF 2007 Clinical practice. The incidentally discovered adrenal mass. N Engl J Med 356:601-610 (Pubitemid 46220820)
2. Cawood TJ, Hunt PJ, O'Shea D, Cole D, Soule S 2009 Recommended evaluation of adrenal incidentalomas is costly, has high false-positive rates and confers a risk of fatal cancer that is similar to the risk of the adrenal lesion becoming malignant; time for a rethink? Eur J Endocrinol 161:513-527
3. Mansmann G, Lau J, Balk E, Rothberg M, Miyachi Y, Bornstein SR 2004 The clinically inapparent adrenal mass: update in diagnosis and management. Endocr Rev 25:309-340 (Pubitemid 38528713)
4. Kloos RT, Gross MD, Francis IR, Korobkin M, Shapiro B 1995 Incidentally discovered adrenal masses. Endocr Rev 16:460-484
5. Barzon L, Sonino N, Fallo F, Palu G, Boscaro M 2003 Prevalence and natural history of adrenal incidentalomas. Eur J Endocrinol 149:273-285 (Pubitemid 37304697)
6. Bovio S, Cataldi A, Reimondo G, Sperone P, Novello S, Berruti A, Borasio P, Fava C, Dogliotti L, Scagliotti GV, Angeli A, Terzolo M 2006 Prevalence of adrenal incidentaloma in a contemporary computerized tomography series. J Endocrinol Invest 29:298-302 (Pubitemid 43905318)
7. Young Jr WF 2000 Management approaches to adrenal incidentalomas. A view from Rochester, Minnesota. Endocrinol Metab Clin North Am 29:159-185
8. Piga A, Bracci R, Porfiri E, Cellerino R 1995 Metastatic tumors of the adrenals. Minerva Endocrinol 20:79-83
9. Lee JE, Evans DB, Hickey RC, Sherman SI, Gagel RF, Abbruzzese MC, Abbruzzese JL 1998 Unknown primary cancer presenting as an adrenal mass: frequency and implications for diagnostic evaluation of adrenal incidentalomas. Surgery 124:1115-1122 (Pubitemid 28555203)
10. Pantalone KM, Gopan T, Remer EM, Faiman C, Ioachimescu AG, Levin HS, Siperstein A, Berber E, Shepardson LB, Bravo EL, Hamrahian AH 2010 Change in adrenal mass size as a predictor of a malignant tumor. Endocr Pract 16:577-587
11. Fassnacht M, Kenn W, Allolio B 2004 Adrenal tumors: how to establish malignancy? J Endocrinol Invest 27:387-399
12. Hamrahian AH, Ioachimescu AG, Remer EM, Motta-Ramirez G, Bogabathina H, Levin HS, Reddy S, Gill IS, Siperstein A, Bravo EL 2005 Clinical utility of noncontrast computed tomography attenuation value (Hounsfield units) to differentiate adrenal adenomas/ hyperplasias from nonadenomas: Cleveland Clinic experience. J Clin Endocrinol Metab 90:871-877 (Pubitemid 40279211)
13. Kloos RT, Gross MD, Shapiro B, Francis IR, Korobkin M, Thompson NW 1997 Diagnostic dilemma of small incidentally discovered adrenal masses: role for 131I-6β-iodomethyl-norcholesterol scintigraphy. World J Surg 21:36-40 (Pubitemid 27026714)
14. Copeland PM 1983 The incidentally discovered adrenal mass. Ann Intern Med 98:940-945 (Pubitemid 13053411)
15. van Erkel AR, van Gils AP, Lequin M, Kruitwagen C, Bloem JL, Falke TH 1994 CT and MR distinction of adenomas and nonadenomas of the adrenal gland. J Comput Assist Tomogr 18:432-438 (Pubitemid 24142994)
16. Hussain S, Belldegrun A, Seltzer SE, Richie JP, Gittes RF, Abrams HL 1985 Differentiation of malignant from benign adrenal masses: predictive indices on computed tomography. Am J Roentgenol 144:61-65
17. Guerrero LA 1985 Diagnostic and therapeutic approach to incidental adrenal mass. Urology 26:435-440 (Pubitemid 17045569)
18. Arnaldi G, Masini AM, Giacchetti G, Taccaliti A, Faloia E, Mantero F 2000 Adrenal incidentaloma. Braz J Med Biol Res 33: 1177-1189
19. Mantero F, Terzolo M, Arnaldi G, Osella G, Masini AM, Alì A, Giovagnetti M, Opocher G, Angeli A 2000 A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab 85:637-644
20. Grumbach MM, Biller BM, Braunstein GD, Campbell KK, Carney JA, Godley PA, Harris EL, Lee JK, Oertel YC, Posner MC, Schlechte JA, Wieand HS 2003 Management of the clinically inapparent adrenal mass ("incidentaloma") . Ann Intern Med 138: 424-429 (Pubitemid 36262654)
21. Zeiger MA, Thompson GB, Duh QY, Hamrahian AH, Angelos P, Elaraj D, Fishman E, Kharlip J 2009 The American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons medical guidelines for the management of adrenal incidentalomas. Endocr Pract 15(Suppl 1):1-20
22. Mantero F, Arnaldi G 2000 Management approaches to adrenal incidentalomas. A view from Ancona, Italy. Endocrinol Metab Clin North Am 29:107-125, ix
23. Graham DJ, McHenry CR 1998 The adrenal incidentaloma: guidelines for evaluation and recommendations for management. Surg Oncol Clin N Am 7:749-764 (Pubitemid 28436538)
24. Thompson GB, Young Jr WF 2003 Adrenal incidentaloma. Curr Opin Oncol 15:84-90 (Pubitemid 36135653)
25. Sturgeon C, Shen WT, Clark OH, Duh QY, Kebebew E 2006 Risk assessment in 457 adrenal cortical carcinomas: how much does tumor size predict the likelihood of malignancy? J Am Coll Surg 202:423-430
26. Lee MJ, Hahn PF, Papanicolaou N, Egglin TK, Saini S, Mueller PR, Simeone JF 1991 Benign and malignant adrenal masses: CT distinction with attenuation coefficients, size, and observer analysis. Radiology 179:415-418
27. Singer AA, Obuchowski NA, Einstein DM, Paushter DM 1994 Metastasis or adenoma? Computed tomographic evaluation of the adrenal mass. Cleve Clin J Med 61:200-205
28. Miyake H, Takaki H, Matsumoto S, Yoshida S, Maeda T, Mori H 1995 Adrenal nonhyperfunctioning adenoma and nonadenoma: CT attenuation value as discriminative index. Abdom Imaging 20: 559-562
29. McNicholas MM, Lee MJ, Mayo-Smith WW, Hahn PF, Boland GW, Mueller PR 1995 An imaging algorithm for the differential diagnosis of adrenal adenomas and metastases. AJR Am J Roentgenol 165:1453-1459
30. Korobkin M, Brodeur FJ, Yutzy GG, Francis IR, Quint LE, Dunnick NR, Kazerooni EA 1996 Differentiation of adrenal adenomas from nonadenomas using CT attenuation values. AJR Am J Roentgenol 166:531-536 (Pubitemid 26065155)
31. Macari M, Rofsky NM, Naidich DP, Megibow AJ 1998 Non-small cell lung carcinoma: usefulness of unenhanced helical CT of the adrenal glands in an unmonitored environment. Radiology 209: 807-812 (Pubitemid 28564919)
32. Boland GW, Lee MJ, Gazelle GS, Halpern EF, McNicholas MM, Mueller PR 1998 Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature. AJR Am J Roentgenol 171:201-204 (Pubitemid 28308675)
33. Nwariaku FE, Champine J, Kim LT, Burkey S, O'keefe G, Snyder 3rd WH 2001 Radiologic characterization of adrenal masses: the role of computed tomography-derived attenuation values. Surgery 130:1068-1071
34. Szolar DH, Kammerhuber F 1997 Quantitative CT evaluation of adrenal gland masses: a step forward in the differentiation between adenomas and nonadenomas? Radiology 202:517-521
35. Schteingart DE 2000 Management approaches to adrenal incidentalomas. A view from Ann Arbor, Michigan. Endocrinol Metab Clin North Am 29:127-139, ix-x
36. Anagnostis P, Efstathiadou Z, Polyzos SA, Tsolakidou K, Litsas ID, Panagiotou A, Kita M 2010 Long term follow-up of patients with adrenal incidentalomas-a single center experience and review of the literature. Exp Clin Endocrinol Diabetes 118:610-616
37. Libè R, Dall'Asta C, Barbetta L, Baccarelli A, Beck-Peccoz P, Ambrosi B 2002 Long-term follow-up study of patients with adrenal incidentalomas. Eur J Endocrinol 147:489-494 (Pubitemid 35238144)
38. Barzon L, Scaroni C, Sonino N, Fallo F, Paoletta A, Boscaro M 1999 Risk factors and long-term follow-up of adrenal incidentalomas. J Clin Endocrinol Metab 84:520-526 (Pubitemid 29075678)
39. Blake MA, Cronin CG, Boland GW 2010 Adrenal imaging. AJR Am J Roentgenol 194:1450-1460
40. Caoili EM, Korobkin M, Francis IR, Cohan RH, Platt JF, Dunnick NR, Raghupathi KI 2002 Adrenal masses: characterization with combined unenhanced and delayed enhanced CT. Radiology 222: 629-633 (Pubitemid 34215205)
41. Beierwaltes WH, Sturman MF, Ryo U, Ice RD 1974 Imaging functional nodules of the adrenal glands with 131-I-19-iodocholesterol. J Nucl Med 15:246-251
42. Charbonnel B, Chatal JF, Ozanne P 1981 Does the corticoadrenal adenoma with "pre-Cushing's syndrome" exist? J Nucl Med 22: 1059-1061
43. Terzolo M, Bovio S, Pia A, Osella G, Borretta G, Angeli A, Reimondo G 2007 Subclinical Cushing's syndrome. Arq Bras Endocrinol Metabol 51:1272-1279
44. Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, Young Jr WF, Montori VM 2008 Case detection, diagnosis, and treatment of patients with primary aldosteronism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 93:3266-3281
45. Reincke M 2000 Subclinical Cushing's syndrome. Endocrinol Metab Clin North Am 29:43-56 (Pubitemid 30151888)
46. Terzolo M, Osella G, Alì A, Borretta G, Cesario F, Paccotti P, Angeli A 1998 Subclinical Cushing's syndrome in adrenal incidentaloma. Clin Endocrinol (Oxf) 48:89-97 (Pubitemid 28122438)
47. Valli N, Catargi B, Ronci N, Vergnot V, Leccia F, Ferriere JM, Chene G, Grenier N, Laurent F, Tabarin A 2001 Biochemical screening for subclinical cortisol-secreting adenomas amongst adrenal incidentalomas. Eur J Endocrinol 144:401-408 (Pubitemid 32409594)
48. Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, Montori VM 2008 The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 93:1526-1540 (Pubitemid 351656485)
49. Morelli V, Masserini B, Salcuni AS, Eller-Vainicher C, Savoca C, Viti R, Coletti F, Guglielmi G, Battista C, Iorio L, Beck-Peccoz P, Ambrosi B, Arosio M, Scillitani A, Chiodini I 2010 Subclinical hypercortisolism: correlation between biochemical diagnostic criteria and clinical aspects. Clin Endocrinol (Oxf) 73:161-166
50. Eller-Vainicher C, Morelli V, Salcuni AS, Battista C, Torlontano M, Coletti F, Iorio L, Cairoli E, Beck-Peccoz P, Arosio M, Ambrosi B, Scillitani A, Chiodini I 2010 Accuracy of several parameters of hypothalamic-pituitary- adrenal axis activity in predicting before surgery the metabolic effects of the removal of an adrenal incidentaloma. Eur J Endocrinol 163:925-935
51. Mitchell IC, Auchus RJ, Juneja K, Chang AY, Holt SA, Snyder 3rd WH, Nwariaku FE 2007 "Subclinical Cushing's syndrome" is not subclinical: improvement after adrenalectomy in 9 patients. Surgery 142:900-905; discussion 905.e1
52. Tauchmanovà L, Rossi R, Biondi B, Pulcrano M, Nuzzo V, Palmieri EA, Fazio S, Lombardi G 2002 Patients with subclinical Cushing's syndromedueto adrenaladenomahave increased cardiovascular risk. J Clin Endocrinol Metab 87:4872-4878 (Pubitemid 35316318)
53. Erbil Y, Ademoolu E, Ozbey N, Barbaros U, Yanik BT, Salmaslioolu A, Bozbora A, Ozarmaoan S 2006 Evaluation of the cardiovascular risk in patients with subclinical Cushing syndrome before and after surgery. World J Surg 30:1665-1671 (Pubitemid 44411221)
54. Barzon L, Fallo F, Sonino N, Boscaro M 2001 Overnight dexamethasone suppression of cortisol is associated with radiocholesterol uptake patterns in adrenal incidentalomas. Eur J Endocrinol 145:223-224 (Pubitemid 32707610)
55. Nunes ML, Vattaut S, Corcuff JB, Rault A, Loiseau H, Gatta B, Valli N, Letenneur L, Tabarin A 2009 Late-night salivary cortisol for diagnosis of overt and subclinical Cushing's syndrome in hospitalized and ambulatory patients. J Clin Endocrinol Metab 94: 456-462
56. Fagour C, Bardet S, Rohmer V, Arimone Y, Lecomte P, Valli N, Tabarin A 2009 Usefulness of adrenal scintigraphy in the follow-up of adrenocortical incidentalomas: a prospective multicenter study. Eur J Endocrinol 160:257-264
57. Donadio F, Morelli V, Salcuni AS, Eller-Vainicher C, Carletto M, Castellani M, Dellavedova L, Scillitani A, Beck-Peccoz P, Chiodini I 2009 Role of adrenal gland scintigraphy in patients with subclinical hypercortisolism and incidentally discovered adrenal mass. J Endocrinol Invest 32:576-580
58. Tsuiki M, Tanabe A, Takagi S, Naruse M, Takano K 2008 Cardiovascular risks and their long-term clinical outcome in patients with subclinical Cushing's syndrome. Endocr J 55:737-745
59. Vassilatou E, Vryonidou A, Michalopoulou S, Manolis J, Caratzas J, Phenekos C, Tzavara I 2009 Hormonal activity of adrenal incidentalomas: results from a long-term follow-up study. Clin Endocrinol (Oxf) 70:674-679
60. Barzon L, Fallo F, Sonino N, Boscaro M 2002 Development of overt Cushing's syndrome in patients with adrenal incidentaloma. Eur J Endocrinol 146:61-66 (Pubitemid 34126421)
61. Chiodini I, Tauchmanovà L, Torlontano M, Battista C, Guglielmi G, Cammisa M, Colao A, Carnevale V, Rossi R, Di Lembo S, Trischitta V, Scillitani A 2002 Bone involvement in eugonadal male patients with adrenal incidentaloma and subclinical hypercortisolism. J Clin Endocrinol Metab 87:5491-5494 (Pubitemid 36034349)
62. Rossi R, Tauchmanova L, Luciano A, Di Martino M, Battista C, Del Viscovo L, Nuzzo V, Lombardi G 2000 Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features. J Clin Endocrinol Metab 85:1440-1448 (Pubitemid 32289484)
63. Chiodini I, Losa M, Pavone G, Trischittal V, Scillitani A 2004 Pregnancy in Cushing's disease shortly after treatment by gammaknife radiosurgery. J Endocrinol Invest 27:954-956 (Pubitemid 40124192)
64. Terzolo M, Pia A, Alì A, Osella G, Reimondo G, Bovio S, Daffara F, Procopio M, Paccotti P, Borretta G, Angeli A 2002 Adrenal incidentaloma: a new cause of the metabolic syndrome? J Clin Endocrinol Metab 87:998-1003
65. Garrapa GG, Pantanetti P, Arnaldi G, Mantero F, Faloia E 2001 Body composition and metabolic features in women with adrenal incidentaloma or Cushing's syndrome. J Clin Endocrinol Metab 86:5301-5306 (Pubitemid 33070251)
66. Toniato A, Merante-Boschin I, Opocher G, Pelizzo MR, Schiavi F, Ballotta E 2009 Surgical versus conservative management for subclinical Cushing syndrome in adrenal incidentalomas: a prospective randomized study. Ann Surg 249:388-391
67. Tauchmanovà L, Pivonello R, De Martino MC, Rusciano A, De Leo M, Ruosi C, Mainolfi C, Lombardi G, Salvatore M, Colao A 2007 Effects of sex steroids on bone in women with subclinical or overt endogenous hypercortisolism. Eur J Endocrinol 157:359-366 (Pubitemid 47603542)
68. Chiodini I, Guglielmi G, Battista C, Carnevale V, Torlontano M, Cammisa M, Trischitta V, Scillitani A 2004 Spinal volumetric bone mineral density and vertebral fractures in female patients with adrenal incidentalomas: the effects of subclinical hypercortisolism and gonadal status. J Clin Endocrinol Metab 89:2237-2241 (Pubitemid 38619858)
69. Chiodini I, Viti R, Coletti F, Guglielmi G, Battista C, Ermetici F, Morelli V, Salcuni A, Carnevale V, Urbano F, Muscarella S, Ambrosi B, Arosio M, Beck-Peccoz P, Scillitani A 2009 Eugonadal male patients with adrenal incidentalomas and subclinical hypercortisolism have increased rate of vertebral fractures. Clin Endocrinol (Oxf) 70:208-213
70. Morelli V, Donadio F, Eller-Vainicher C, Cirello V, Olgiati L, Savoca C, Cairoli E, Salcuni AS, Beck-Peccoz P, Chiodini I 2010 Role of glucocorticoid receptor polymorphism in adrenal incidentalomas. Eur J Clin Invest 40:803-811
71. Chiodini I, Morelli V, Salcuni AS, Eller-Vainicher C, Torlontano M, Coletti F, Iorio L, Cuttitta A, Ambrosio A, Vicentini L, Pellegrini F, Copetti M, Beck-Peccoz P, Arosio M, Ambrosi B, Trischitta V, Scillitani A 2010 Beneficial metabolic effects of prompt surgical treatment in patients with an adrenal incidentaloma causing biochemical hypercortisolism. J Clin Endocrinol Metab 95:2736-2745
72. Terzolo M, Reimondo G, Angeli A 2009 Definition of an optimal strategy to evaluate and follow-up adrenal incidentalomas: time for further research. Eur J Endocrinol 161:529-532
73. Marko NF, Gonugunta VA, Hamrahian AH, Usmani A, Mayberg MR, Weil RJ 2009 Use of morning serum cortisol level after transsphenoidal resection of pituitary adenoma to predict the need for long-term glucocorticoid supplementation. J Neurosurg 111:540-544
74. Eller-Vainicher C, Morelli V, Salcuni AS, Torlontano M, Coletti F, Iorio L, Cuttitta A, Ambrosio A, Vicentini L, Carnevale V, Beck- Peccoz P, Arosio M, Ambrosi B, Scillitani A, Chiodini I 2010 Postsurgical hypocortisolism after removal of an adrenal incidentaloma: is it predictable by an accurate endocrinological work-up before surgery? Eur J Endocrinol 162:91-99
75. Bülow B, Ahrén B 2002 Adrenal incidentaloma - experience of a standardized diagnostic program in the Swedish prospective study. J Intern Med 252:239-246
76. Kasperlik-Załuska AA, Otto M, Cichocki A, Rosłonowska E, Słowiñska-Srzednicka J, Jeske W, Papierska L, Zgliczyñski W 2008 Incidentally discovered adrenal tumors: a lesson from observation of 1,444 patients. Horm Metab Res 40:338-341 (Pubitemid 351859445)
77. Stenström G, Svärdsudd K 1986 Pheochromocytoma in Sweden 1958-1981. An analysis of the National Cancer Registry Data. Acta Med Scand 220:225-232
78. Adams JE, Johnson RJ, Rickards D, Isherwood I 1983 Computed tomography in adrenal disease. Clin Radiol 34:39-49 (Pubitemid 13172878)
79. Päivänsalo M, Lähde S, Merikanto J, Kallionen M 1988 Computed tomography in primary and secondary adrenal tumours. Acta Radiol 29:519-522
80. Miyake H, Maeda H, Tashiro M, Suzuki K, Nagatomo H, Aikawa H, Ashizawa A, Iechika S, Moriuchi A 1989 CT of adrenal tumors: frequency and clinical significance of low-attenuation lesions. AJR Am J Roentgenol 152:1005-1007 (Pubitemid 19125131)
81. Korobkin M, Brodeur FJ, Francis IR, Quint LE, Dunnick NR, Londy F 1998 CT time-attenuation washout curves of adrenal adenomas and nonadenomas. AJR Am J Roentgenol 170:747-752 (Pubitemid 28106677)
82. Laursen K, Damgaard-Pedersen K 1980 CT for pheochromocytoma diagnosis. AJR Am J Roentgenol 134:277-280 (Pubitemid 10187541)
83. Caoili EM, Korobkin M, Francis IR, Cohan RH, Dunnick NR 2000 Delayed enhanced CT of lipid-poor adrenal adenomas. AJR Am J Roentgenol 175:1411-1415
84. Motta-Ramirez GA, Remer EM, Herts BR, Gill IS, Hamrahian AH 2005 Comparison of CT findings in symptomatic and incidentally discovered pheochromocytomas. AJR Am J Roentgenol 185:684-688
85. Pacak K, Eisenhofer G, Ahlman H, Bornstein SR, Gimenez-Roqueplo AP, Grossman AB, Kimura N, Mannelli M, McNicol AM, Tischler AS 2007 Pheochromocytoma: recommendations for clinical practice from the First International Symposium, October 2005. Nat Clin Pract Endocrinol Metab 3:92-102 (Pubitemid 46146962)
86. d'Herbomez M, Forzy G, Bauters C, Tierny C, Pigny P, Carnaille B, Pattou F, Wémeau JL, Rouaix N 2007 An analysis of the biochemical diagnosis of 66 pheochromocytomas. Eur J Endocrinol 156:569-575
87. Bravo EL, Tagle R 2003 Pheochromocytoma: state-of-the-art and future prospects. Endocr Rev 24:539-553 (Pubitemid 37056243)
88. Lenders JW, Pacak K, Walther MM, Linehan WM, Mannelli M, Friberg P, Keiser HR, Goldstein DS, Eisenhofer G 2002 Biochemical diagnosis of pheochromocytoma: which test is best? JAMA 287:1427-1434
89. Lenders JW 2009 Biochemical diagnosis of pheochromocytoma and paraganglioma. Ann Endocrinol Paris 70:161-165
90. Lenders JW, Pacak K, Eisenhofer G 2002 New advances in the biochemical diagnosis of pheochromocytoma: moving beyond catecholamines. Ann NY Acad Sci 970:29-40 (Pubitemid 35286081)
91. Hemmelgarn BR, McAlister FA, Grover S, Myers MG, McKay DW, Bolli P, Abbott C, Schiffrin EL, Honos G, Burgess E, Mann K, Wilson T, Penner B, Tremblay G, Milot A, Chockalingam A, Touyz RM, Tobe SW 2006 The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension. Part I - blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol 22:573-581
92. Sawka AM, Jaeschke R, Singh RJ, Young Jr WF 2003 A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. J Clin Endocrinol Metab 88:553-558 (Pubitemid 36207789)
93. Anagnostis P, Karagiannis A, Tziomalos K, Kakafika AI, Athyros VG, Mikhailidis DP 2009 Adrenal incidentaloma: a diagnostic challenge. Hormones (Athens) 8:163-184
94. Adler JT, Meyer-Rochow GY, Chen H, Benn DE, Robinson BG, Sippel RS, Sidhu SB 2008 Pheochromocytoma: current approaches and future directions. Oncologist 13:779-793
95. Pacak K 2007 Preoperative management of the pheochromocytoma patient. J Clin Endocrinol Metab 92:4069-4079
96. Goldstein RE, O'Neill Jr JA, Holcomb 3rd GW, Morgan 3rd WM, Neblett 3rd WW, Oates JA, Brown N, Nadeau J, Smith B, Page DL, Abumrad NN, Scott Jr HW 1999 Clinical experience over 48 years with pheochromocytoma. Ann Surg 229:755-764; discussion 764-756
97. Bravo EL 2004 Pheochromocytoma: current perspectives in the pathogenesis, diagnosis, and management. Arq Bras Endocrinol Metabol 48:746-750
98. Pan DL, Li HZ, Ji ZG, Zeng ZP 2005 [Effects of doxazosin mosylate and phenoxybenzamine in preoperative volume expansion of pheochromocytoma: a comparative study in 38 cases]. Zhonghua Yi Xue Za Zhi 85:1403-1405
99. Ulchaker JC, Goldfarb DA, Bravo EL, Novick AC 1999 Successful outcomes in pheochromocytoma surgery in the modern era. J Urol 161:764-767 (Pubitemid 29422362)
100. Perry RR, Keiser HR, Norton JA, Wall RT, Robertson CN, Travis W, Pass HI, Walther MM, Linehan WM 1990 Surgical management of pheochromocytoma with the use of metyrosine. Ann Surg 212:621-628
101. Steinsapir J, Carr AA, Prisant LM, Bransome Jr ED 1997 Metyrosine and pheochromocytoma. Arch Intern Med 157:901-906 (Pubitemid 28337041)
102. Cheah WK, Clark OH, Horn JK, Siperstein AE, Duh QY 2002 Laparoscopic adrenalectomy for pheochromocytoma. World J Surg 26:1048-1051 (Pubitemid 36920307)
103. Bravo EL 1994 Evolving concepts in the pathophysiology, diagnosis, and treatment of pheochromocytoma. Endocr Rev 15:356-368 (Pubitemid 24180793)
104. Amar L, Servais A, Gimenez-Roqueplo AP, Zinzindohoue F, Chatellier G, Plouin PF 2005 Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma. J Clin Endocrinol Metab 90: 2110-2116 (Pubitemid 40586247)
105. Rossi GP, Bernini G, Desideri G, Fabris B, Ferri C, Giacchetti G, Letizia C, Maccario M, Mannelli M, Matterello MJ, Montemurro D, Palumbo G, Rizzoni D, Rossi E, Pessina AC, Mantero F 2006 Renal damage in primary aldosteronism: results of the PAPY Study. Hypertension 48:232-238 (Pubitemid 44309817)
106. McKenzie TJ, Lillegard JB, Young Jr WF, Thompson GB 2009 Aldosteronomas - state of the art. Surg Clin North Am 89:1241-1253
107. Aso Y, Homma Y 1992 A survey on incidental adrenal tumors in Japan. J Urol 147:1478-1481
108. Caplan RH, Strutt PJ, Wickus GG 1994 Subclinical hormone secretion by incidentally discovered adrenal masses. Arch Surg 129: 291-296 (Pubitemid 24103322)
109. Kim HY, Kim SG, Lee KW, Seo JA, Kim NH, Choi KM, Baik SH, Choi DS 2005 Clinical study of adrenal incidentaloma in Korea. Korean J Intern Med 20:303-309 (Pubitemid 47050826)
110. Young Jr WF, Klee GG 1988 Primary aldosteronism. Diagnostic evaluation. Endocrinol Metab Clin North Am 17:367-395
111. Hiramatsu K, Yamada T, Yukimura Y, Komiya I, Ichikawa K, Ishihara M, Nagata H, Izumiyama T 1981 A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients. Arch Intern Med 141:1589-1593 (Pubitemid 12234064)
112. Munver R, Yates J 2010 Diagnosis and surgical management for primary hyperaldosteronism. Curr Urol Rep 11:51-57
113. Mosso L, Carvajal C, González A, Barraza A, Avila F, Montero J, Huete A, Gederlini A, Fardella CE 2003 Primary aldosteronism and hypertensive disease. Hypertension 42:161-165 (Pubitemid 36944590)
114. Stowasser M, Gordon RD 2004 Primary aldosteronism - careful investigation is essential and rewarding. Mol Cell Endocrinol 217: 33-39 (Pubitemid 38596626)
115. Bravo EL 1994 Primary aldosteronism. Issues in diagnosis and management. Endocrinol Metab Clin North Am 23:271-283
116. Tan YY, Ogilvie JB, Triponez F, Caron NR, Kebebew EK, Clark OH, Duh QY 2006 Selective use of adrenal venous sampling in the lateralization of aldosterone-producing adenomas. World J Surg 30:879-885; discussion 886-877
117. Lumachi F, Ermani M, Basso SM, Armanini D, Iacobone M, Favia G 2005 Long-term results of adrenalectomy in patients with aldosterone- producing adenomas: multivariate analysis of factors affecting unresolved hypertension and review of the literature. Am Surg 71:864-869
118. Young WF 2007 Primary aldosteronism: renaissance of a syndrome. Clin Endocrinol (Oxf) 66:607-618 (Pubitemid 46699525)
119. Bravo EL, Dustan HP, Tarazi RC 1975 Selective hypoaldosteronism despite prolonged pre- and postoperative hyperreninemia in primary aldosteronism. J Clin Endocrinol Metab 41:611-617
120. Mattsson C, Young Jr WF 2006 Primary aldosteronism: diagnostic and treatment strategies. Nat Clin Pract Nephrol 2:198-208; quiz, 1 p following 230
121. Vanderveen KA, Thompson SM, Callstrom MR, Young Jr WF, Grant CS, Farley DR, Richards ML, Thompson GB 2009 Biopsy of pheochromocytomas and paragangliomas: potential for disaster. Surgery 146:1158-1166
122. Angeli A, Osella G, Alì A, Terzolo M 1997 Adrenal incidentaloma: an overview of clinical and epidemiological data from the National Italian Study Group. Horm Res 47:279-283 (Pubitemid 27196466)
123. Bülow B, Jansson S, Juhlin C, Steen L, Thorén M, Wahrenberg H, Valdemarsson S, Wängberg B, Ahrén B 2006 Adrenal incidentaloma - follow-up results from a Swedish prospective study. Eur J Endocrinol 154:419-423
124. Dwamena BA, Kloos RT, Fendrick AM, Gross MD, Francis IR, Korobkin MT, Shapiro B 1998 Diagnostic evaluation of the adrenal incidentaloma: decision and cost-effectiveness analyses. J Nucl Med 39:707-712 (Pubitemid 28175852)